Christine Ring, Chief Legal Officer, on August 03, 2026, sold 16,589 shares in Nurix Therapeutics (NRIX) for $382,358. Following the Form 4 filing with the SEC, Ring has control over a total of 9,110 common shares of the company, with 9,110 shares held directly.
SEC Filing: